Metsmall 1000 Tablet SR is a controlled-release oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus. Each tablet contains 1000mg of metformin, a biguanide derivative, which exerts its therapeutic effect by reducing glucose production in the liver and improving insulin sensitivity. The sustained-release formulation allows for a gradual release of the active ingredient over an extended period, thereby providing a consistent therapeutic effect. Metsmall 1000 Tablet SR is designed to improve glycemic control in patients with type 2 diabetes, and its once-daily dosing schedule simplifies treatment regimens. The product is contraindicated in patients with severe renal impairment, acute or chronic metabolic acidosis, and those taking medications that may increase the risk of lactic acidosis. As with all metformin products, Metsmall 1000 Tablet SR carries a risk of lactic acidosis, which is more common in patients with underlying conditions such as heart failure, respiratory failure, or sepsis. Patients should be monitored regularly for signs and symptoms of lactic acidosis and discontinued if they occur.

Dosage & How to Use